Voluntary recall addresses Alprostadil

Published on: Friday, August 20, 2021

Teva Pharmaceuticals USA has issued a voluntary recall of a single lot of injectable Alprostadil (prostaglandin) to address potential risks related to discoveries of aseptic areas of manufacturing.

The lot information is:

• 31329295B, expiration date 01/2022

If your institution has stock from this affected lot, please contact your supplier for additional instructions regarding product returns.